The success of TNF alpha in isolated limb perfusion for irresectable extremity soft tissue sarcomas, melanoma and carcinomas: observations in patients and preclinical perfusion models.
Eggermont
A M
AM
University Hospital Rotterdam-Daniel den Hoed Cancer Center, The Netherlands.
D000818:Animals; D002277:Carcinoma / Q000628:therapy*; D010478:Chemotherapy, Cancer, Regional Perfusion; D005121:Extremities; D006801:Humans; D008081:Liposomes; D008545:Melanoma / Q000628:therapy*; D009504:Neutrophils / Q000502:physiology; D009569:Nitric Oxide / Q000502:physiology; D051381:Rats; D012509:Sarcoma / Q000628:therapy*; D012513:Sarcoma, Experimental / Q000628:therapy; D012878:Skin Neoplasms / Q000628:therapy*; D012983:Soft Tissue Neoplasms / Q000473:pathology / Q000628:therapy*; D014409:Tumor Necrosis Factor-alpha / Q000627:therapeutic use*
D008081:Liposomes; D014409:Tumor Necrosis Factor-alpha; D009569:Nitric Oxide